// App-Quantinova.ai

15325 2014 AHA : Overexpression of MicroRNA-126 Promotes Angiogenesis in a Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) and Tyrosine Kinase with Immunoglobulin-like and EGF-like Domains 2 (Tie2) Dependent Manner in Hindlimb Chronic Ischemia

Researchers

Presenter

  • Wei J Cao

Principal Investigators

  • Dmitriy Rudenko

  • Hao H Chen

  • Michael A Kuliszewski

  • Howard Leong-Poi

Medical Centers

  • St. Michael's Hosp, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • Kinase Insert Domain Receptor

  • MicroRNA 126

  • microRNA-126

  • Vascular endothelial growth factor A

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved